WITHDRAWN: lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy

Mol Ther. 2021 Nov 8:S1525-0016(21)00574-8. doi: 10.1016/j.ymthe.2021.11.003. Online ahead of print.

Abstract

This article has been withdrawn at the request of the editor-in-chief. Following publication of this article, the editor-in-chief discovered evidence of image duplication in Figures 1I, 1J, 3F, S5B, and S6B. Given the duplication of several western blots representing several gene products, the editor-in-chief has lost faith in the findings presented in this article. The authors maintain that these image duplications were the result of errors in file management and do not affect the conclusions of the study. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Keywords: Linc00173; YB1; glucose metabolism; in vitro; in vivo; long noncoding RNA; molecular mechanisms; multidrug resistance; small cell lung cancer; therapeutic targets; tissue samples.

Publication types

  • Retracted Publication